Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab*
暂无分享,去创建一个
R. Simes | T. Price | N. Tebbutt | Chee Khoon Lee | C. Murone | J. Hardingham | J. Wrin | A. Townsend | K. Wilson | A. Weickhardt | C. Lee